Hamed Alavi
Known title: Chief Technology OfficerCIK: 0001964081
Associated companies
Transaction History
| NVNO | ▲ Buy | Option Exercise | 8,334 | $30K | 3/13/2024 | View on chart |
| NVNO | ▼ Sell | Open Market | 8,334 | $52K | 3/13/2024 | View on chart |
| NVNO | ▲ Buy | Option Exercise | 8,334 | $30K | 3/13/2024 | View on chart |
| NVNO | ▼ Sell | Open Market | 8,334 | $52K | 3/13/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit
enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit. enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.